《Bmj Evidence-based Medicine》是一本以English為主的未開(kāi)放獲取國(guó)際優(yōu)秀期刊,中文名稱Bmj 循證醫(yī)學(xué),本刊主要出版、報(bào)道醫(yī)學(xué)-MEDICINE, GENERAL & INTERNAL領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果,介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展,探討行業(yè)發(fā)展的思路和方法,以促進(jìn)學(xué)術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄,為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用,也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為9,最新CiteScore 指數(shù)為8.9。
英文介紹
Bmj Evidence-based Medicine雜志英文介紹
BMJ Evidence-Based Medicine (BMJ EBM) publishes original evidence-based research, insights, and opinions on health care issues. We focus on the implementation of evidence-based medicine and provide fundamental and core tools, methods, and concepts relevant to credible and impactful evidence. BMJ EBM is a transformative journal compliant with Plan S, adhering to the highest industry standards for publication policies and publishing ethics. BMJ is a founding member of COPE (Committee on Publication Ethics), which provides a forum for publishers and editors of scientific journals to discuss issues related to the integrity of work submitted or published in their journals.
中科院SCI分區(qū)
Bmj Evidence-based Medicine雜志中科院分區(qū)信息
2023年12月升級(jí)版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 3區(qū)
小類:
MEDICINE, GENERAL & INTERNAL 醫(yī)學(xué):內(nèi)科 3區(qū)
2022年12月升級(jí)版
綜述:否
TOP期刊:否
大類:醫(yī)學(xué) 3區(qū)
小類:
MEDICINE, GENERAL & INTERNAL 醫(yī)學(xué):內(nèi)科 2區(qū)
該雜志是一本國(guó)際優(yōu)秀雜志,在國(guó)際上有較高的學(xué)術(shù)影響力,行業(yè)關(guān)注度很高,已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄,該雜志在MEDICINE, GENERAL & INTERNAL綜合專業(yè)領(lǐng)域?qū)I(yè)度認(rèn)可很高,對(duì)稿件內(nèi)容的創(chuàng)新性和學(xué)術(shù)性要求很高,作為一本國(guó)際優(yōu)秀雜志,一般投稿過(guò)審時(shí)間都較長(zhǎng),投稿過(guò)審時(shí)間平均 ,如果想投稿該刊要做好時(shí)間安排。版面費(fèi)不祥。該雜志近兩年未被列入預(yù)警名單,建議您投稿。如您想了解更多投稿政策及投稿方案,請(qǐng)咨詢客服。